China Authorizes Five Companies to Make COVID-19 Vaccines

BEIJING--June 8, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--China has authorized five companies for COVID-19 vaccine production: Sinopharm Beijing Institute, SinoVac, CanSinoBIO, Sinopharm Wuhan Institute and Anhui Zhifei Longcom. Industrial Info is tracking five active COVID-19 vaccine projects, worth $698 million in China, two of which will kick off in the second half of this year.